The Use of Parp Inhibitors in Advanced Ovarian Cancer with Robert Coleman - a podcast by BMJ Group

In this episode of the IJGC podcast, Editor-in-Chief, Dr. Pedro Ramirez, is joined by Dr. Robert Coleman (Twitter: @rcoledude) from MD Anderson Cancer Center in Houston, Texas. They discuss how parp inhibitors work and how they have come into play with gynecologic oncology, including how to discuss parp inhibitors with patients, recommendations for patient monitoring and follow up, and the future of ovarian cancer treatment.

Further episodes of IJGC Podcast

Further podcasts by BMJ Group

Website of BMJ Group